Prevalence and correlates of sleep disorders in Parkinson’s disease: a polysomnographic study

Detalhes bibliográficos
Autor(a) principal: Alatriste-Booth,Vanessa
Data de Publicação: 2015
Outros Autores: Rodríguez-Violante,Mayela, Camacho-Ordoñez,Azyadeh, Cervantes-Arriaga,Amin
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Arquivos de neuro-psiquiatria (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000300241
Resumo: Objective Sleep disorders in Parkinson’s disease are very common. Polysomnography (PSG) is considered the gold standard for diagnosis. The aim of the present study is to assess the prevalence of nocturnal sleep disorders diagnosed by polysomnography and to determine the associated clinical factors. Method A total of 120 patients with Parkinson’s disease were included. All patients underwent a standardized overnight, single night polysomnography. Results Ninety-four (78.3%) patients had an abnormal PSG. Half of the patients fulfilled criteria for sleep apnea-hypopnea syndrome (SAHS); rapid eye movement behavior disorder (RBD) was present in 37.5%. Characteristics associated with SAHS were age (p = 0.049) and body mass index (p = 0.016). Regarding RBD, age (p < 0.001), left motor onset (p = 0.047) and levodopa equivalent dose (p = 0.002) were the main predictors. Conclusion SAHS and RBD were the most frequent sleep disorders. Higher levodopa equivalent dose and body mass index appear to be risk factors for RBD and SAHS, respectively.
id ABNEURO-1_ed9d5fcae8ab2ce7e1e0e4727ce03dc9
oai_identifier_str oai:scielo:S0004-282X2015000300241
network_acronym_str ABNEURO-1
network_name_str Arquivos de neuro-psiquiatria (Online)
repository_id_str
spelling Prevalence and correlates of sleep disorders in Parkinson’s disease: a polysomnographic studyParkinson’s diseasesleep disorderspolysomnography Objective Sleep disorders in Parkinson’s disease are very common. Polysomnography (PSG) is considered the gold standard for diagnosis. The aim of the present study is to assess the prevalence of nocturnal sleep disorders diagnosed by polysomnography and to determine the associated clinical factors. Method A total of 120 patients with Parkinson’s disease were included. All patients underwent a standardized overnight, single night polysomnography. Results Ninety-four (78.3%) patients had an abnormal PSG. Half of the patients fulfilled criteria for sleep apnea-hypopnea syndrome (SAHS); rapid eye movement behavior disorder (RBD) was present in 37.5%. Characteristics associated with SAHS were age (p = 0.049) and body mass index (p = 0.016). Regarding RBD, age (p < 0.001), left motor onset (p = 0.047) and levodopa equivalent dose (p = 0.002) were the main predictors. Conclusion SAHS and RBD were the most frequent sleep disorders. Higher levodopa equivalent dose and body mass index appear to be risk factors for RBD and SAHS, respectively. Academia Brasileira de Neurologia - ABNEURO2015-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000300241Arquivos de Neuro-Psiquiatria v.73 n.3 2015reponame:Arquivos de neuro-psiquiatria (Online)instname:Academia Brasileira de Neurologiainstacron:ABNEURO10.1590/0004-282X20140228info:eu-repo/semantics/openAccessAlatriste-Booth,VanessaRodríguez-Violante,MayelaCamacho-Ordoñez,AzyadehCervantes-Arriaga,Amineng2015-03-19T00:00:00Zoai:scielo:S0004-282X2015000300241Revistahttp://www.scielo.br/anphttps://old.scielo.br/oai/scielo-oai.php||revista.arquivos@abneuro.org1678-42270004-282Xopendoar:2015-03-19T00:00Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologiafalse
dc.title.none.fl_str_mv Prevalence and correlates of sleep disorders in Parkinson’s disease: a polysomnographic study
title Prevalence and correlates of sleep disorders in Parkinson’s disease: a polysomnographic study
spellingShingle Prevalence and correlates of sleep disorders in Parkinson’s disease: a polysomnographic study
Alatriste-Booth,Vanessa
Parkinson’s disease
sleep disorders
polysomnography
title_short Prevalence and correlates of sleep disorders in Parkinson’s disease: a polysomnographic study
title_full Prevalence and correlates of sleep disorders in Parkinson’s disease: a polysomnographic study
title_fullStr Prevalence and correlates of sleep disorders in Parkinson’s disease: a polysomnographic study
title_full_unstemmed Prevalence and correlates of sleep disorders in Parkinson’s disease: a polysomnographic study
title_sort Prevalence and correlates of sleep disorders in Parkinson’s disease: a polysomnographic study
author Alatriste-Booth,Vanessa
author_facet Alatriste-Booth,Vanessa
Rodríguez-Violante,Mayela
Camacho-Ordoñez,Azyadeh
Cervantes-Arriaga,Amin
author_role author
author2 Rodríguez-Violante,Mayela
Camacho-Ordoñez,Azyadeh
Cervantes-Arriaga,Amin
author2_role author
author
author
dc.contributor.author.fl_str_mv Alatriste-Booth,Vanessa
Rodríguez-Violante,Mayela
Camacho-Ordoñez,Azyadeh
Cervantes-Arriaga,Amin
dc.subject.por.fl_str_mv Parkinson’s disease
sleep disorders
polysomnography
topic Parkinson’s disease
sleep disorders
polysomnography
description Objective Sleep disorders in Parkinson’s disease are very common. Polysomnography (PSG) is considered the gold standard for diagnosis. The aim of the present study is to assess the prevalence of nocturnal sleep disorders diagnosed by polysomnography and to determine the associated clinical factors. Method A total of 120 patients with Parkinson’s disease were included. All patients underwent a standardized overnight, single night polysomnography. Results Ninety-four (78.3%) patients had an abnormal PSG. Half of the patients fulfilled criteria for sleep apnea-hypopnea syndrome (SAHS); rapid eye movement behavior disorder (RBD) was present in 37.5%. Characteristics associated with SAHS were age (p = 0.049) and body mass index (p = 0.016). Regarding RBD, age (p < 0.001), left motor onset (p = 0.047) and levodopa equivalent dose (p = 0.002) were the main predictors. Conclusion SAHS and RBD were the most frequent sleep disorders. Higher levodopa equivalent dose and body mass index appear to be risk factors for RBD and SAHS, respectively.
publishDate 2015
dc.date.none.fl_str_mv 2015-03-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000300241
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000300241
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0004-282X20140228
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
dc.source.none.fl_str_mv Arquivos de Neuro-Psiquiatria v.73 n.3 2015
reponame:Arquivos de neuro-psiquiatria (Online)
instname:Academia Brasileira de Neurologia
instacron:ABNEURO
instname_str Academia Brasileira de Neurologia
instacron_str ABNEURO
institution ABNEURO
reponame_str Arquivos de neuro-psiquiatria (Online)
collection Arquivos de neuro-psiquiatria (Online)
repository.name.fl_str_mv Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologia
repository.mail.fl_str_mv ||revista.arquivos@abneuro.org
_version_ 1754212777833005056